Kūlana o nā lula

I ka makahiki 1965, ua hoʻokumu ka European Community i ka Medicines Directive (65/EEC) i mea e hoʻohui ai i nā kānāwai a me nā lula e pili ana i nā lāʻau kanu ma waena o nā ʻāina.I ka makahiki 1988, ua hoʻokumu ka European Community i nā Guidelines for the Management of Herbal Products, i ʻōlelo maopopo ʻia: “He ʻano lāʻau lapaʻau ka lāʻau lapaʻau, a ʻo nā mea ikaika i loko o ia mea he mau mea kanu a hoʻomākaukau paha i ka lāʻau lapaʻau.Pono e laikini ʻia nā lāʻau lapaʻau no ke kūʻai ʻana.Pono e hoʻokō ʻia nā kūlana o ka maikaʻi, palekana a me ka pono ma mua o ke kūʻai ʻia ʻana o kahi huahana.Pono ka palapala noi no ka laikini e hāʻawi i kēia mau ʻike: 1. ʻO ka ʻike qualitative a me quantitative o nā ʻāpana;2. ʻO ka wehewehe ʻana i ke ʻano hana hana;3. Ka hoomalu ana i na mea mua;4. E hoʻokō mau ʻia ka mana maikaʻi a me ka ʻike;5. Ka mana maikaʻi a me ka loiloi o nā huahana i hoʻopau ʻia;6. Ka ʻike ʻana o ka paʻa.I ka makahiki 1990, ua noi ka European Community i ka GMP no ka hana ʻana i nā lāʻau lapaʻau.
I Kekemapa 2005, ua hoʻopaʻa inoa ʻia ka lāʻau lapaʻau kahiko ʻo KlosterfrauMelisana ma Kelemānia.ʻO kēia huahana ka nui o ka mauʻu balsam, ʻala kīwila, angelica, ginger, clove, galangal, Eurogentian, mālama i ka noʻonoʻo a me ka hopohopo, ke poʻo, dysmenorrhea, nalowale o ka ʻai, dyspepsia, ke anu a pēlā aku.Ma UK, aia nā haneli o nā noi no ke kākau inoa ʻana i nā lāʻau lapaʻau kuʻuna, akā i kēia manawa ʻaʻohe mea no ka lāʻau lapaʻau Kina.

ʻO ka manaʻo kumu o nā lāʻau lapaʻau ma ʻAmelika Hui Pū ʻIa, ʻo ia ka mea e maopopo ai ka hoʻohui ʻana i ke kemika, a ma ke ʻano o ka hoʻomākaukau ʻana i ka hui, pono e akaka ka pharmacodynamics o kēlā me kēia mea kemika a me nā hopena o kā lākou pilina ma ka pono a me nā mea make.Ma lalo o ka mana o ka manaʻo orthodox o ka lāʻau lapaʻau, ʻaʻole maikaʻi loa ka ʻike o ka US FDA i ka lāʻau lapaʻau, me ka lāʻau lapaʻau kuʻuna Kina, no laila ʻaʻole ia e ʻike i ka lāʻau lapaʻau maoli.Eia nō naʻe, ma lalo o ke kaomi o ka nui o ka mālama olakino a me ka manaʻo nui o ka lehulehu, ua hoʻoholo ka US Congress i ka Dietary Supplement Health Education Act (DSHEA) ma 1994 ma o ka hoʻoikaika ʻole ʻana a me ka hoʻopaʻa ʻana o kekahi mau ʻoihana liʻiliʻi a me ka liʻiliʻi. lāʻau lapaʻau Kina ma ke ʻano he meaʻai meaʻai.Hiki ke ʻōlelo ʻia he huahana kūikawā ma waena o ka meaʻai a me ka lāʻau lapaʻau.ʻOiai ʻaʻole hiki ke hōʻike ʻia ka hōʻailona kikoʻī, hiki ke hōʻike ʻia kāna hana mālama olakino.

ʻO nā lāʻau lapaʻau kūlohelohe i hana ʻia a kūʻai ʻia ma ʻAmelika Hui Pū ʻIa he kūlana kānāwai, ʻo ia hoʻi, ʻike ʻia lākou no ka hoʻohana ʻana i ka pale ʻana a me ka mālama ʻana i nā maʻi.I ka makahiki 2000, ma ka pane ʻana i ke koi lehulehu, ua hoʻoholo ka Pelekikena o ʻAmelika Hui Pū ʻIa e hoʻokumu i ka "****** Policy Council on Complementary and Alternative Medicine", me 20 mau lālā i koho pololei ʻia e ka Pelekikena e kūkākūkā i nā alakaʻi kulekele o ka hoʻokō. a me nā lāʻau lapaʻau ʻē aʻe a e ʻimi i kona waiwai kūpono.Ma kāna hōʻike kūhelu i ka Pelekikena a me ka ʻAhaʻōlelo i ka makahiki 2002, ua hoʻokomo ʻo ****** i ka "lāʻau Kina kuʻuna" i loko o ka ʻōnaehana hoʻohui a me nā lāʻau ʻē aʻe.

I nā makahiki i hala iho nei, ua hoʻoikaika ka FDA i ka hoʻoponopono hoʻoponopono o nā lāʻau lapaʻau maoli.I ka makahiki 2003, ua hoʻomaka ʻo ia e hoʻokō i ka hoʻokele GMP no nā mea hoʻohui meaʻai a hoʻonohonoho i nā kūlana koʻikoʻi no ka hana ʻana a me ka hōʻailona ʻana i nā mea hoʻohui meaʻai.Ua paʻi ka FDA i ka Guidelines for the Development of Plant Drugs ma ka pūnaewele a noi i nā manaʻo ma ka honua holoʻokoʻa.Hōʻike aʻe nā Kumukānāwai alakaʻi he ʻokoʻa nā lāʻau lāʻau botanical mai nā lāʻau kemika, no laila, ʻokoʻa ko lākou mau koi ʻenehana mai nā mea hope, a wehewehe i kekahi mau ʻano o nā lāʻau botanical: ʻo ka hui ʻana o nā lāʻau botanical ka mea maʻamau he hui ʻana o nā mea he nui, akā. ma mua o ka hui hoʻokahi;ʻAʻole maopopo nā kemika a pau o nā lāʻau lapaʻau ******;I ka hapanui o nā hihia, ʻaʻole i hoʻoholo ʻia nā mea hana o nā lāʻau lapaʻau ******;I kekahi mau hihia, ʻaʻole maopopo a maopopo ka hana olaola o ka lāʻau lapaʻau;Nui nā ʻano hana no ka hoʻomākaukau ʻana a me ka hoʻoponopono ʻana i nā lāʻau lapaʻau maʻamau;Loaʻa i nā lāʻau Botanical ka ʻike nui a lōʻihi hoʻi i ka noi kanaka.ʻAʻole i ʻike ʻia nā hopena ʻino i ka wā lōʻihi a me ka hoʻohana nui ʻana o ka lāʻau lapaʻau i loko o ke kino kanaka.Ua kūʻai ʻia kekahi mau lāʻau lapaʻau ma ke ʻano he huahana olakino a i ʻole mea hoʻohui meaʻai.

Ma muli o ka hoʻomaopopo ʻana o FDA i nā lāʻau kanu lāʻau, ʻokoʻa nā koi ʻenehana no nā lāʻau kanu i loko o nā Kumukānāwai Alakaʻi mai nā mea no nā lāʻau kemika, ʻo ia hoʻi: ʻokoʻa nā koi ʻenehana no ka noiʻi preclinical;Hiki ke hana maʻalahi ka hoʻokolohua pharmacokinetic.Hoʻomaʻamaʻa kūikawā no ka hoʻomākaukau ʻana i nā mea kanu hui;Pono ka ʻenehana lāʻau lapaʻau i ka hana maʻalahi;Ua hōʻemi ʻia nā koi ʻenehana o ka pharmacology a me toxicology.Hōʻike nā alakaʻi i kahi lele kūpono i ke ala o ka FDA i nā lāʻau lapaʻau maoli, me nā lāʻau lapaʻau Kina.ʻO ka hoʻololi nui ʻana o ke kulekele aupuni o ʻAmelika e pili ana i ka lāʻau lapaʻau i hoʻokumu i nā kūlana kumu no ka lāʻau lapaʻau e komo i ka mākeke ʻAmelika.
Ma kahi o Veregen, i ʻae ʻia, ma kahi o 60 a 70 mau botanicals aia i ka pipeline a hiki i kēia manawa.